Paula L. Jacobsen , Eileen M. Thorley , Christopher Curran
{"title":"自我报告抑郁症患者的性功能障碍和抗抑郁药使用:一项横断面调查研究","authors":"Paula L. Jacobsen , Eileen M. Thorley , Christopher Curran","doi":"10.1016/j.npbr.2020.03.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Sexual dysfunction negatively impacts quality of life and relationship satisfaction in patients with major depressive disorder (MDD). This study’s objective was to understand real-world experiences with sexual dysfunction in patients with MDD.</p></div><div><h3>Methods</h3><p>This survey study included 483 participants (≥18 years old) from the PatientsLikeMe® network who reported an MDD diagnosis. Sexual dysfunction (self-attributed and as evaluated by the Changes in Sexual Functioning Questionnaire [CSFQ-14]), relationship satisfaction, depression severity, and medication adherence were assessed.</p></div><div><h3>Results</h3><p>Of the patients currently taking antidepressants (N = 405), sexual dysfunction was reported in approximately half (self-attributed, 52 % and per CSFQ-14, 56 %). Forty-eight percent of these patients indicated they would continue medication until sexual side effects abated. Fewer than half of patients with self-attributed sexual dysfunction, reported for at least one antidepressant, had spoken with their doctor about sexual side effects; of these, about one-third were switched to another antidepressant. Sexual dysfunction was associated with depression severity, diminished relationship satisfaction, and lower self-esteem in patients currently taking antidepressants.</p></div><div><h3>Limitations</h3><p>This is a convenience sample; data are based on self-report without independent verification of the diagnoses. The cross-sectional design also limits conclusions about causality and directionality. The generalizability of the findings is limited, as the patient sample was predominantly female, white, college educated, and moderately to severely depressed.</p></div><div><h3>Conclusions</h3><p>New strategies for managing sexual dysfunction in patients with MDD who are taking antidepressants are critically needed to provide these patients with the best chance for successful treatment outcomes.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 57-64"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.03.002","citationCount":"9","resultStr":"{\"title\":\"Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression: A cross-sectional survey study\",\"authors\":\"Paula L. Jacobsen , Eileen M. Thorley , Christopher Curran\",\"doi\":\"10.1016/j.npbr.2020.03.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Sexual dysfunction negatively impacts quality of life and relationship satisfaction in patients with major depressive disorder (MDD). This study’s objective was to understand real-world experiences with sexual dysfunction in patients with MDD.</p></div><div><h3>Methods</h3><p>This survey study included 483 participants (≥18 years old) from the PatientsLikeMe® network who reported an MDD diagnosis. Sexual dysfunction (self-attributed and as evaluated by the Changes in Sexual Functioning Questionnaire [CSFQ-14]), relationship satisfaction, depression severity, and medication adherence were assessed.</p></div><div><h3>Results</h3><p>Of the patients currently taking antidepressants (N = 405), sexual dysfunction was reported in approximately half (self-attributed, 52 % and per CSFQ-14, 56 %). Forty-eight percent of these patients indicated they would continue medication until sexual side effects abated. Fewer than half of patients with self-attributed sexual dysfunction, reported for at least one antidepressant, had spoken with their doctor about sexual side effects; of these, about one-third were switched to another antidepressant. Sexual dysfunction was associated with depression severity, diminished relationship satisfaction, and lower self-esteem in patients currently taking antidepressants.</p></div><div><h3>Limitations</h3><p>This is a convenience sample; data are based on self-report without independent verification of the diagnoses. The cross-sectional design also limits conclusions about causality and directionality. The generalizability of the findings is limited, as the patient sample was predominantly female, white, college educated, and moderately to severely depressed.</p></div><div><h3>Conclusions</h3><p>New strategies for managing sexual dysfunction in patients with MDD who are taking antidepressants are critically needed to provide these patients with the best chance for successful treatment outcomes.</p></div>\",\"PeriodicalId\":49756,\"journal\":{\"name\":\"Neurology Psychiatry and Brain Research\",\"volume\":\"36 \",\"pages\":\"Pages 57-64\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.npbr.2020.03.002\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurology Psychiatry and Brain Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0941950019301708\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology Psychiatry and Brain Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0941950019301708","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression: A cross-sectional survey study
Background
Sexual dysfunction negatively impacts quality of life and relationship satisfaction in patients with major depressive disorder (MDD). This study’s objective was to understand real-world experiences with sexual dysfunction in patients with MDD.
Methods
This survey study included 483 participants (≥18 years old) from the PatientsLikeMe® network who reported an MDD diagnosis. Sexual dysfunction (self-attributed and as evaluated by the Changes in Sexual Functioning Questionnaire [CSFQ-14]), relationship satisfaction, depression severity, and medication adherence were assessed.
Results
Of the patients currently taking antidepressants (N = 405), sexual dysfunction was reported in approximately half (self-attributed, 52 % and per CSFQ-14, 56 %). Forty-eight percent of these patients indicated they would continue medication until sexual side effects abated. Fewer than half of patients with self-attributed sexual dysfunction, reported for at least one antidepressant, had spoken with their doctor about sexual side effects; of these, about one-third were switched to another antidepressant. Sexual dysfunction was associated with depression severity, diminished relationship satisfaction, and lower self-esteem in patients currently taking antidepressants.
Limitations
This is a convenience sample; data are based on self-report without independent verification of the diagnoses. The cross-sectional design also limits conclusions about causality and directionality. The generalizability of the findings is limited, as the patient sample was predominantly female, white, college educated, and moderately to severely depressed.
Conclusions
New strategies for managing sexual dysfunction in patients with MDD who are taking antidepressants are critically needed to provide these patients with the best chance for successful treatment outcomes.
期刊介绍:
Neurology, Psychiatry & Brain Research publishes original papers and reviews in
biological psychiatry,
brain research,
neurology,
neuropsychiatry,
neuropsychoimmunology,
psychopathology,
psychotherapy.
The journal has a focus on international and interdisciplinary basic research with clinical relevance. Translational research is particularly appreciated. Authors are allowed to submit their manuscript in their native language as supplemental data to the English version.
Neurology, Psychiatry & Brain Research is related to the oldest German speaking journal in this field, the Centralblatt fur Nervenheilkunde, Psychiatrie und gerichtliche Psychopathologie, founded in 1878. The tradition and idea of previous famous editors (Alois Alzheimer and Kurt Schneider among others) was continued in modernized form with Neurology, Psychiatry & Brain Research. Centralblatt was a journal of broad scope and relevance, now Neurology, Psychiatry & Brain Research represents a journal with translational and interdisciplinary perspective, focusing on clinically oriented research in psychiatry, neurology and neighboring fields of neurosciences and psychology/psychotherapy with a preference for biologically oriented research including basic research. Preference is given for papers from newly emerging fields, like clinical psychoimmunology/neuroimmunology, and ideas.